Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,087 public trials 1,777 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies

NCT03837184

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Tokyo Women's Medical University Tokyo, Japan
  • Pusan National University Yangsan Hospital Yangsan, Gyeongsangnam-do, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

NCT03505099

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Children's Hospital Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

NCT03306277

Conditions
Central Nervous System Diseases, Gene Therapy, Motor Neuron Disease, +6 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Children's Hospital Orlando, Florida, United States
View all 16 locations
View Trial Details
Completed

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

NCT04818671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator site 6 - US0010032 Carlsbad, California, United States
  • Investigator Site 47 - US0010021 Palo Alto, California, United States
  • Investigator Site 45 - US0010108 Boca Raton, Florida, United States
  • Investigator site 4 - US0010110 Port Charlotte, Florida, United States
View all 47 locations
View Trial Details

Related conditions